Screening for depression and anxiety in lung cancer patients: A real‐world study using GAD‐7 and HADS

Abstract

AbstractBackgroundThe psychological well‐being of lung cancer patients is critical in‐patient care but frequently overlooked.MethodsThis study, employing a cross‐sectional, questionnaire‐based design, aimed to elucidate the prevalence of depressive and anxiety symptoms among lung cancer patients and identify associated risk factors. Participants' demographic, medical history, disease stage, and pathology were systematically collected. Psychological assessment was conducted using the general anxiety disorder‐7 (GAD‐7), patient health questionnaire‐9 (PHQ‐9), and hospital anxiety and depression scale (HADS). Statistical analyses were performed using SPSS software (version 25.0).ResultsOut of 294 distributed questionnaires, 247 lung cancer patients were included in the final analysis, with an average completion time of 9.08 min. Notably, 32.4% exhibited depressive symptoms, while 30% displayed signs of anxiety. A significant correlation was found between both depressive and anxiety symptoms and a history of tobacco and alcohol consumption. Specifically, increased nicotine dependence and greater cumulative tobacco use were linked to higher rates of depressive symptoms, whereas cumulative alcohol consumption was associated with increased risks of anxiety symptoms.ConclusionThe study affirms the feasibility of GAD‐7, PHQ‐9, and HADS as screening tools for depressive and anxiety symptoms in lung cancer patients. It further highlights tobacco and alcohol consumption as significant risk factors for poor psychological health in this population.